journal
MENU ▼
Read by QxMD icon Read
search

Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology

journal
https://www.readbyqxmd.com/read/30222483/positron-emission-tomography-guided-therapy-of-aggressive-non-hodgkin-lymphoma-standard-of-care-after-the-petal-study
#1
Christian Gisselbrecht
No abstract text is available yet for this article.
September 17, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30222482/reply-to-h-j-a-adams-et-al
#2
Reid W Merryman, Ann LaCasce
No abstract text is available yet for this article.
September 17, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30222481/unproven-clinical-value-of-interim-fdg-pet-in-aggressive-non-hodgkin-lymphoma
#3
Hugo J A Adams, Thomas C Kwee
No abstract text is available yet for this article.
September 17, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30222480/reply-to-h-j-a-adams-et-al-and-c-gisselbrecht
#4
Ulrich Dührsen, Stefan Müller, Jan Rekowski, Andreas Hüttmann
No abstract text is available yet for this article.
September 17, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30216124/guideline-for-the-management-of-clostridium-difficile-infection-in-children-and-adolescents-with-cancer-and-pediatric-hematopoietic-stem-cell-transplantation-recipients
#5
Caroline Diorio, Paula D Robinson, Roland A Ammann, Elio Castagnola, Kelley Erickson, Adam Esbenshade, Brian T Fisher, Gabrielle M Haeusler, Susan Kuczynski, Thomas Lehrnbecher, Robert Phillips, Sandra Cabral, L Lee Dupuis, Lillian Sung
Purpose The aim of this work was to develop a clinical practice guideline for the prevention and treatment of Clostridium difficile infection (CDI) in children and adolescents with cancer and pediatric hematopoietic stem-cell transplantation (HSCT) patients. Methods An international multidisciplinary panel of experts in pediatric oncology and infectious diseases with patient advocate representation was convened. We performed systematic reviews of randomized controlled trials for the prevention or treatment of CDI in any population and considered the directness of the evidence to children with cancer and pediatric HSCT patients...
September 14, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30216123/long-term-risk-of-venous-thromboembolism-in-survivors-of-childhood-cancer-a-report-from-the-childhood-cancer-survivor-study
#6
Arin L Madenci, Brent R Weil, Qi Liu, Andrew J Murphy, Todd M Gibson, Yutaka Yasui, Wendy M Leisenring, Rebecca M Howell, Christopher L Tinkle, Larissa Nekhlyudov, Lisa R Diller, Gregory T Armstrong, Kevin C Oeffinger, Christopher B Weldon
Purpose To estimate the incidence of late-occurring venous thromboembolism (VTE) among survivors of childhood cancer and to identify risk factors for VTE to facilitate diagnosis and prevention. Methods The Childhood Cancer Survivor Study is a multi-institutional cohort of 24,355 5-year childhood cancer survivors (diagnosed between 1970 and 1999; median age at last follow-up, 28.7 years [range, 5.6 to 58.9 years]; median follow-up since diagnosis, 21.3 years [range, 5.0 to 39.2 years]) and 5,051 sibling participants...
September 14, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212301/should-crizotinib-take-it-all-in-ros1-positive-non-small-cell-lung-cancer
#7
Liang Zeng, Nong Yang, Yongchang Zhang
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212300/high-risk-localized-prostate-cancer-how-important-is-the-addition-of-brachytherapy-to-external-beam-radiotherapy
#8
Alfonso Gomez-Iturriaga, Juanita Crook
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212299/reply-to-d-m-green
#9
David B Dix, Nita L Seibel, Yueh-Yun Chi, Geetika Khanna, Elizabeth A Mullen, James I Geller, John A Kalapurakal, Peter F Ehrlich, Marcio H Malogolowkin, Conrad V Fernandez, Jeffrey S Dome
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212298/the-american-brachytherapy-society-and-the-american-radium-society-appropriate-use-criteria-genitourinary-committee-endorse-the-american-society-of-clinical-oncology-cancer-care-ontario-guidelines
#10
Albert J Chang, Sean McBride, Mira Keyes, Hans T Chung, Brian J Davis, Brett W Cox, Juanita Crook, David J Demanes, I Chow Hsu, Mitchell Kamrava, Daniel J Krauss, Gerard Morton, Peter F Orio Iii, Mack Roach Iii, Puja S Venkat, Eric Vigneault, Michael J Zelefsky
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212297/addressing-financial-barriers-to-patient-participation-in-clinical-trials-asco-policy-statement
#11
Karen M Winkfield, Jonathan K Phillips, Steven Joffe, Michael T Halpern, Dana S Wollins, Beverly Moy
Research conducted through clinical trials is essential for evaluating new treatment modalities, establishing new standards of cancer care, and ultimately improving and prolonging the lives of patients with cancer. However, participation in trials has been low, and this is attributable to various factors including patient financial barriers. Such financial barriers include the rising cost of cancer care; a lack of transparency in coverage policy; and the perception of ethical, compliance, or institutional impediments to patient financial support...
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212296/reply-to-l-zeng-et-al
#12
Yi-Long Wu, Koichi Goto
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212295/national-cancer-institute-breast-cancer-steering-committee-working-group-report-on-meaningful-and-appropriate-end-points-for-clinical-trials-in-metastatic-breast-cancer
#13
Andrew D Seidman, Louise Bordeleau, Louis Fehrenbacher, William E Barlow, Jane Perlmutter, Lawrence Rubinstein, Suparna B Wedam, Dawn L Hershman, Jennifer Fallas Hayes, Lynn Pearson Butler, Mary Lou Smith, Meredith M Regan, Julia A Beaver, Laleh Amiri-Kordestani, Priya Rastogi, Jo Anne Zujewski, Larissa A Korde
Purpose To provide evidence-based consensus recommendations on choice of end points for clinical trials in metastatic breast cancer, with a focus on biologic subtype and line of therapy. Methods The National Cancer Institute Breast Cancer Steering Committee convened a working group of breast medical oncologists, patient advocates, biostatisticians, and liaisons from the Food and Drug Administration to conduct a detailed curated systematic review of the literature, including original reports, reviews, and meta-analyses, to determine the current landscape of therapeutic options, recent clinical trial data, and natural history of four biologic subtypes of breast cancer...
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212294/should-i-have-lied
#14
Hyo Jin Ryu, Jeong-Seon Ryu
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212293/treatment-of-stage-iv-favorable-histology-wilms-tumor-with-lung-metastases
#15
Daniel M Green
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212292/treating-patients-with-bladder-cancer-is-there-an-ethical-obligation-to-include-smoking-cessation-counseling
#16
Matthew Mossanen, Joshua Caldwell, Guru Sonpavde, Lisa Soleymani Lehmann
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212291/cost-effectiveness-of-chimeric-antigen-receptor-t-cell-therapy-in-relapsed-or-refractory-pediatric-b-cell-acute-lymphoblastic-leukemia
#17
John K Lin, Benjamin J Lerman, James I Barnes, Brian C Boursiquot, Yuan Jin Tan, Alex Q L Robinson, Kara L Davis, Douglas K Owens, Jeremy D Goldhaber-Fiebert
Purpose The anti-CD19 chimeric antigen receptor T-cell therapy tisagenlecleucel was recently approved to treat relapsed or refractory pediatric acute lymphoblastic leukemia. With a one-time infusion cost of $475,000, tisagenlecleucel is currently the most expensive oncologic therapy. We aimed to determine whether tisagenlecleucel is cost effective compared with currently available treatments. Methods Markov modeling was used to evaluate tisagenlecleucel in pediatric relapsed or refractory acute lymphoblastic leukemia from a US health payer perspective over a lifetime horizon...
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30212290/reply-to-a-j-chang-et-al-and-a-gomez-iturriaga-et-al
#18
Daniel E Spratt, Peter C Carroll
No abstract text is available yet for this article.
September 13, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30204546/dose-intensification-improves-the-outcome-of-ewing-sarcoma
#19
Richard Gorlick, Katherine A Janeway, Peter C Adamson
No abstract text is available yet for this article.
September 12, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30204536/feasibility-of-implementing-the-patient-reported-outcomes-version-of-the-common-terminology-criteria-for-adverse-events-in-a-multicenter-trial-ncctg-n1048
#20
Ethan Basch, Amylou C Dueck, Lauren J Rogak, Sandra A Mitchell, Lori M Minasian, Andrea M Denicoff, Jennifer K Wind, Mary C Shaw, Narre Heon, Qian Shi, Brenda Ginos, Garth D Nelson, Jeffrey P Meyers, George J Chang, Harvey J Mamon, Martin R Weiser, Tatjana Kolevska, Bryce B Reeve, Deborah Watkins Bruner, Deborah Schrag
Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable patient reporting of symptomatic adverse events in oncology clinical research. This study was designed to assess the feasibility and resource requirements associated with implementing PRO-CTCAE in a multicenter trial. Methods Patients with locally advanced rectal cancer enrolled in the National Cancer Institute-sponsored North Central Cancer Treatment Group (Alliance) Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and Total Mesorectal Excision trial were asked to self-report 30 PRO-CTCAE items weekly from home during preoperative therapy, and every 6 months after surgery, via either the Web or an automated telephone system...
September 11, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
journal
journal
20146
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"